Cargando…
Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
Several clinical trials have substantiated the efficacy of the co-administration of statins like atorvastatin (ATO) and fibrates. Without information currently available about the interaction between the two drugs, a pharmacokinetic study was conducted to investigate the effect when both drugs were...
Autores principales: | Patiño-Rodríguez, Omar, Martínez-Medina, Rosa María, Torres-Roque, Irma, Martínez-Delgado, Maricela, Mares-García, América Susana, Escobedo-Moratilla, Abraham, Covarrubias-Pinedo, Amador, Arzola-Paniagua, Angélica, Herrera-Torres, José Luis, Pérez-Urizar, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310268/ https://www.ncbi.nlm.nih.gov/pubmed/25688207 http://dx.doi.org/10.3389/fphar.2015.00004 |
Ejemplares similares
-
Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014) -
The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus
por: Qasim, Muhammad, et al.
Publicado: (2022) -
Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010) -
Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits
por: Flores-Castillo, Cristóbal, et al.
Publicado: (2019) -
Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin
por: Han, Ji Soo, et al.
Publicado: (2018)